Letter: Pension Policies

You are to be commended for the timely article "New Policies Offer Pension Choices To Academic Scientists" (The Scientist, March 5, 1990, page 25). Julia King correctly pointed out that there is the catch that some of the more flexible policies ". . . must first be adopted by the university where the professors are employed." She went on to suggest that employees can lobby for their employers to adopt the new policies. Despite the fact that TIAA-CREF insists that contracts are with individuals

Written byCedric Chernick
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

You are to be commended for the timely article "New Policies Offer Pension Choices To Academic Scientists" (The Scientist, March 5, 1990, page 25). Julia King correctly pointed out that there is the catch that some of the more flexible policies ". . . must first be adopted by the university where the professors are employed." She went on to suggest that employees can lobby for their employers to adopt the new policies.

Despite the fact that TIAA-CREF insists that contracts are with individuals, it still permits such control to be exercised by employers. There are some 350,000 individuals who hold TIAA-CREF contracts who are no longer working for academic institutions. For those individuals, their options are controlled by their former employers. Further, while TIAA-CREF informs such persons of the options that are available, no one has the responsibility of informing former employees of the options chosen by their former ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo